miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
Francesca Maria Orlandella(Istituti di Ricovero e Cura a Carattere Scientifico), Giuliana Salvatore(Parthenope University of Naples)
Cited by 37
Related Papers
TWIST1 Plays a Pleiotropic Role in Determining the Anaplastic Thyroid Cancer Phenotype
|The Journal of Clinical Endocrinology & Metabolism|2011|42
<i>TWIST1</i>/miR-584/<i>TUSC2</i> pathway induces resistance to apoptosis in thyroid cancer cells
|Oncotarget|2016|30
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
|International Journal of Molecular Sciences|2020|19